JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB177736

Anti-B3GALT2 antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal B3GALT2 antibody. Suitable for IHC-P, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human B3GALT2.

View Alternative Names

Beta3Gal-T2, Beta3GalT2, UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2, B3GALT2

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-B3GALT2 antibody (AB177736)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-B3GALT2 antibody (AB177736)

Immunohistochemical analysis of paraffin-embedded Human heart tissue labeling B3GALT2 with ab177736 at 1/50 dilution (left panel). The right panel is with blocking peptide.

Immunocytochemistry/ Immunofluorescence - Anti-B3GALT2 antibody (AB177736)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-B3GALT2 antibody (AB177736)

Immunofluorescent analysis of A549 cells labeling B3GALT2 with ab177736 at 1/100 dilution (left panel). The right panel is with blocking peptide.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, ICC/IF

applications

Immunogen

Synthetic Peptide within Human B3GALT2. The exact immunogen used to generate this antibody is proprietary information.

O43825

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/500", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }
style
left-column
style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab177736 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Storage buffer
pH: 7 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.88% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

B3GALT2 also known as Beta-13-galactosyltransferase 2 is an enzyme with a molecular weight of approximately 43 kDa. This protein mostly functions within the Golgi apparatus where it facilitates carbohydrate biosynthesis. The enzyme adds galactose in a beta-13 linkage to N-acetylglucosamine residues on glycoproteins and glycolipids. Expression of B3GALT2 occurs widely across tissues with notable levels in the liver and kidney.
Biological function summary

B3GALT2 plays a role in the biosynthesis of glycoproteins and glycolipids. These processes are essential for cell-cell communication and molecular stability on the cell surface. The enzyme operates as a part of the larger family of glycosyltransferases. It does not typically form complexes functioning independently to carry out its catalytic activities within cells. The resulting glycan structures contribute significantly to maintaining cellular homeostasis and signaling mechanisms.

Pathways

The regulation of cell surface glycosylation requires the involvement of B3GALT2. It is actively engaged in pathways such as N-glycan biosynthesis and the formation of glycosphingolipids. B3GALT2 works in coordination with other glycosyltransferases like ST3GAL1 to ensure the correct assembly of glycan chains. These pathways directly influence processes like cell adhesion and immune response modulation.

Abnormalities in B3GALT2 expression relate to conditions such as congenital disorders of glycosylation and certain kidney diseases. Altered enzymatic activity can lead to improper glycosylation patterns affecting protein function and stability. In these disorders B3GALT2 might have interactions with proteins involved in endoplasmic reticulum-associated degradation playing a role in the molecular pathology observed in affected cells.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Beta-1,3-galactosyltransferase that transfers galactose from UDP-galactose to substrates with a terminal beta-N-acetylglucosamine (beta-GlcNAc) residue. Can also utilize substrates with a terminal galactose residue, albeit with lower efficiency. Involved in the biosynthesis of the carbohydrate moieties of glycolipids and glycoproteins. Inactive towards substrates with terminal alpha-N-acetylglucosamine (alpha-GlcNAc) or alpha-N-acetylgalactosamine (alpha-GalNAc) residues.
See full target information B3GALT2
style
left-column

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Cellular and molecular neurobiology 43:1957-1974 PubMed36006573

2022

Mild Hypothermia Alleviates Complement C5a-Induced Neuronal Autophagy During Brain Ischemia-Reperfusion Injury After Cardiac Arrest.

Applications

Unspecified application

Species

Unspecified reactive species

Ling Wang,Yuanyuan Sun,Fang Kong,Yi Jiang,Mengmeng An,Beibei Jin,Da Cao,Ruifang Li,Xiaolan Guan,Shuangshuang Liang,Subi Abudurexiti,Ping Gong
View all publications
style
left-column
style
left-column
style
right-column

Complementary Products

Primary Antibodies

AB200376

Anti-Zinc finger MIZ domain-containing protein 1 antibody - N-terminal

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Zinc finger MIZ domain-containing protein 1 antibody - N-terminal (AB200376)

  • 0
  • 0
Primary Antibodies

AB314638

Anti-ZC3H13 antibody [EPR25077-7]

BOND RX™ Validated|20ul selling size|RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ZC3H13 antibody [EPR25077-7] (AB314638)

  • 0
  • 0
Primary Antibodies

AB191536

Anti-PAG608 antibody

Western blot - Anti-PAG608 antibody (AB191536)

  • 0
  • 0
Primary Antibodies

AB14734

Anti-VDAC1/Porin + VDAC3 antibody [20B12AF2] - Mitochondrial Loading Control

Recombinant|Lab Essentials

Western blot - Anti-VDAC1/Porin + VDAC3 antibody [20B12AF2] - Mitochondrial Loading Control (AB14734)

  • 5
  • 52

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com